+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Bioactive Peptides Market - Cumulative Impact of United States Tariffs 2025 - Global Forecast to 2030- Product Image
Bioactive Peptides Market - Cumulative Impact of United States Tariffs 2025 - Global Forecast to 2030- Product Image
Sale

Bioactive Peptides Market - Cumulative Impact of United States Tariffs 2025 - Global Forecast to 2030

  • PDF Icon

    Report

  • 189 Pages
  • May 2025
  • Region: Global, United States
  • 360iResearch™
  • ID: 6055466
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Bioactive Peptides Market grew from USD 4.74 billion in 2024 to USD 5.15 billion in 2025. It is expected to continue growing at a CAGR of 8.84%, reaching USD 7.88 billion by 2030.

The realm of bioactive peptides has emerged as a cornerstone of innovation in health, nutrition, and pharmaceutical arenas. These short chains of amino acids exhibit a remarkable spectrum of physiological activities-from modulating blood pressure to bolstering immune defenses-and their integration into functional foods, nutraceuticals, cosmetics, and drug formulations is gaining unprecedented momentum. As consumer demand pivots toward naturally derived, science-backed ingredients, bioactive peptides offer a compelling value proposition: targeted efficacy combined with safety profiles that align with stringent regulatory standards. By exploring the molecular intricacies of these peptides and understanding their multifaceted applications, industry stakeholders can unlock new avenues for product differentiation, therapeutic advancement, and sustainable growth. This executive summary lays the groundwork for navigating the evolving bioactive peptide landscape, highlighting transformative industry shifts, regulatory forces, segmentation dynamics, regional trajectories, leading innovators, and strategic imperatives for market leadership.

Transformative Shifts in the Bioactive Peptides Landscape

Over the past decade, the industry has witnessed transformative shifts driven by breakthroughs in peptide synthesis, advanced analytical techniques, and a surge in interdisciplinary collaboration. High-throughput screening platforms and machine learning algorithms now accelerate the discovery of novel sequences with optimized stability and bioavailability, enabling developers to tailor peptides for antihypertensive, antimicrobial, antioxidant, and immunomodulatory functions. Concurrently, production paradigms have evolved: enzymatic hydrolysis, fermentation, and recombinant technologies complement traditional chemical synthesis, boosting yields while reducing costs and environmental impact. On the commercialization front, the proliferation of both branded OTC supplements and prescription peptide therapeutics underscores a strategic pivot towards personalized health solutions. As regulatory frameworks adapt to accommodate these innovations, the convergence of R&D prowess and consumer-centric product design is reshaping competitive dynamics, driving collaboration between ingredient suppliers, contract manufacturers, and end-user brands.

Assessing the Cumulative Impact of United States Tariffs for 2025

In anticipation of tariff adjustments slated for 2025, companies importing peptide precursors, lab reagents, and specialized equipment into the United States face significant cost pressures. The cumulative effect of duty increases on key raw materials sourced from Europe, Asia, and the Middle East has prompted supply chain recalibrations. Several manufacturers are responding by localizing enzymatic hydrolysis facilities, forging strategic alliances with domestic fermentation specialists, and repatriating certain recombinant production lines to mitigate exposure. Meanwhile, ingredient formulators are negotiating long-term procurement contracts and exploring substitute feedstocks from plant-based proteins to offset duty hikes on animal-derived materials. This period of adjustment underscores a critical lesson: resilience in the face of trade policy volatility hinges on flexible sourcing strategies, agile production footprints, and proactive stakeholder engagement with customs and regulatory authorities.

Key Segmentation Insights Driving Market Dynamics

A nuanced view of market segmentation reveals the multifaceted nature of bioactive peptide offerings and their end-use applications. When classified by molecular origin, peptides are broadly endogenous or exogenous, serving distinct roles in metabolic regulation and targeted supplementation. A deeper breakdown by source identifies animal-derived sequences from dairy proteins, egg white, marine, and meat, alongside microbial fermentation products, plant-based isolates such as pea, rice, and soy, and fully synthetic constructs. Peptide chain length further distinguishes dipeptide, oligopeptide, polypeptide, and tripeptide categories, each with unique absorption kinetics and functional profiles. Production processes span chemical synthesis, enzymatic hydrolysis, fermentation, and recombinant expression, reflecting diverse cost, purity, and scalability considerations. Functional segmentation highlights peptide applications in blood pressure modulation, antimicrobial defense, oxidative stress reduction, and immune system support. In terms of dosage forms, capsules, liquids, and powders cater to consumer convenience and stability requirements, while distribution channels range from traditional brick-and-mortar outlets to direct-to-consumer platforms such as brand websites and major e-commerce portals. Finally, application fields stretch across cosmetics, functional foods, nutraceuticals, and pharmaceutical formulations, underscoring the versatility of bioactive peptides in addressing health and wellness objectives.

Regional Perspectives and Growth Trajectories

Geographic diversity profoundly shapes regional opportunities and strategic priorities. In the Americas, innovation is propelled by robust funding for clinical research and a mature nutraceutical landscape, driving adoption of peptide-enhanced dietary supplements and cosmeceuticals. Regulatory agencies here prioritize safety and transparent labeling, positioning the region as a testing ground for high-value peptide therapies. Meanwhile, Europe, the Middle East & Africa exhibit a strong emphasis on sustainable sourcing and green manufacturing: local producers leverage agro-industrial byproducts for peptide extraction, and regulatory frameworks increasingly reward eco-friendly processes. In Asia-Pacific, rapid growth is fueled by rising disposable incomes, expanding healthcare infrastructure, and a deep pool of contract research organizations specializing in fermentation and recombinant technologies. Regional hubs in China, Japan, and India are emerging as centers of excellence for large-scale peptide production, capitalizing on cost advantages and technical expertise to serve both domestic and export markets. Together, these regions form an interconnected mosaic of R&D capabilities, regulatory environments, and consumer preferences.

Leading Companies Shaping Innovation and Competition

Innovation and competitive intensity are driven by a diverse set of global players leveraging unique strengths. Abbott Laboratories and Ajinomoto Co., Inc. stand out for their integrated value chains, spanning raw material procurement to finished consumer products. Amgen Inc. and Pfizer Inc. focus on high-potency therapeutic peptides, investing heavily in clinical trials and proprietary delivery systems. Archer Daniels Midland Company and Clariant AG excel in scale and sustainability, converting agricultural feedstocks into cost-effective peptide ingredients. BASF SE and Evonik Industries AG bring advanced polymer chemistry and formulation science to the table, enhancing stability and bioavailability. Specialty firms such as Bachem Holding AG, CPC Scientific Inc., PolyPeptide Group AG, and LipoTrue SL prioritize custom synthesis and rapid turnaround for niche applications. Contract development and manufacturing organizations like Lonza Group, GenScript Biotech Corporation, and Novozymes A/S enable flexible production across fermentation, enzymatic, and recombinant platforms. In the pharmaceutical domain, Eli Lilly and Company, Merck & Co., Inc., Novo Nordisk A/S, and Zealand Pharma A/S drive therapeutic innovation, while nutraceutical leaders such as Glanbia plc, Givaudan SA, Croda International Plc, and Symrise AG champion consumer-driven formulations. Emerging biotech innovators including Ferring Pharmaceuticals Pvt. Ltd., PeptiDream Inc., Protagonist Therapeutics, Inc., and Ashland Inc. round out a competitive ecosystem that spans discovery, manufacturing, and commercialization.

Actionable Recommendations for Industry Leaders

To thrive amid evolving market dynamics, industry leaders should pursue a three-pronged strategy. First, accelerate investment in platform technologies that enable rapid screening and optimization of novel peptide sequences, leveraging artificial intelligence and high-throughput methodologies to reduce time-to-market. Second, diversify supply chains by integrating local production facilities and alternative feedstocks-such as plant-based or microbial sources-to insulate operations from geopolitical and tariff risks. Third, strengthen cross-sector partnerships between ingredient suppliers, contract manufacturers, and end-user brands to co-develop differentiated formulations that resonate with health-conscious consumers. Simultaneously, companies must engage proactively with regulatory bodies to streamline approval pathways, adopt sustainability metrics across the value chain, and enhance digital marketing channels to capture direct consumer insights. By implementing these measures, organizations can secure competitive advantage, drive long-term profitability, and establish leadership in the rapidly evolving bioactive peptide landscape.

Conclusion: Navigating the Future of Bioactive Peptides

Bioactive peptides stand at the intersection of scientific innovation and market opportunity. As the industry advances, success will hinge on the ability to integrate cutting-edge R&D, agile manufacturing, and consumer-oriented product development. Companies that navigate tariff headwinds through diversified sourcing, harness the power of advanced analytics for sequence discovery, and foster collaborative ecosystems will outpace competitors. Regional nuances-from the Americas’ clinical rigor to EMEA’s sustainability ethos and Asia-Pacific’s scale offerings-must inform tailored go-to-market strategies. Looking ahead, a balanced focus on therapeutic validation, formulation innovation, and digital engagement will define winners in this dynamic field. The imperative is clear: embrace data-driven decision-making, elevate product transparency, and forge strategic alliances to unlock the full potential of bioactive peptides.

Market Segmentation & Coverage

This research report categorizes the Bioactive Peptides Market to forecast the revenues and analyze trends in each of the following sub-segmentations:

  • Endogenous
  • Exogenous
  • Animal Derived
    • Dairy Proteins
    • Egg White Proteins
    • Marine Proteins
    • Meat Proteins
  • Microbial Fermentation
  • Plant-Based
    • Pea
    • Rice
    • Soy
  • Synthetic
  • Dipeptide
  • Oligopeptide
  • Polypeptide
  • Tripeptide
  • Chemical Synthesis
  • Enzymatic Hydrolysis
  • Fermentation
  • Recombinant Production
  • Antihypertensive
  • Antimicrobial
  • Antioxidant
  • Immunomodulatory
  • Capsule
  • Liquid
  • Powder
  • Offline
  • Online
    • Brand Websites
    • E-Commerce Websites
  • Cosmetics
  • Functional Foods
  • Nutraceuticals
  • Pharmaceuticals

This research report categorizes the Bioactive Peptides Market to forecast the revenues and analyze trends in each of the following sub-regions:

  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom

This research report categorizes the Bioactive Peptides Market to delves into recent significant developments and analyze trends in each of the following companies:

  • Abbott Laboratories
  • Ajinomoto Co., Inc.
  • Amgen Inc.
  • Archer Daniels Midland Company
  • Ashland Inc.
  • Bachem Holding AG
  • BASF SE
  • Clariant AG
  • CPC Scientific Inc.
  • Croda International Plc
  • Eli Lilly and Company
  • Evonik Industries AG
  • Ferring Pharmaceuticals Pvt. Ltd.
  • GenScript Biotech Corporation
  • Givaudan SA
  • Glanbia plc
  • Koninklijke DSM N.V.
  • LipoTrue SL
  • Lonza Group
  • Merck & Co., Inc.
  • Novo Nordisk A/S
  • Novozymes A/S
  • PeptiDream Inc.
  • Pfizer Inc.
  • PolyPeptide Group AG
  • Protagonist Therapeutics, Inc.
  • Symrise AG
  • Zealand Pharma A/S

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Bioactive Peptides Market, by Type
8.1. Introduction
8.2. Endogenous
8.3. Exogenous
9. Bioactive Peptides Market, by Source
9.1. Introduction
9.2. Animal Derived
9.2.1. Dairy Proteins
9.2.2. Egg White Proteins
9.2.3. Marine Proteins
9.2.4. Meat Proteins
9.3. Microbial Fermentation
9.4. Plant-Based
9.4.1. Pea
9.4.2. Rice
9.4.3. Soy
9.5. Synthetic
10. Bioactive Peptides Market, by Type
10.1. Introduction
10.2. Dipeptide
10.3. Oligopeptide
10.4. Polypeptide
10.5. Tripeptide
11. Bioactive Peptides Market, by Production Process
11.1. Introduction
11.2. Chemical Synthesis
11.3. Enzymatic Hydrolysis
11.4. Fermentation
11.5. Recombinant Production
12. Bioactive Peptides Market, by Function
12.1. Introduction
12.2. Antihypertensive
12.3. Antimicrobial
12.4. Antioxidant
12.5. Immunomodulatory
13. Bioactive Peptides Market, by Formulation
13.1. Introduction
13.2. Capsule
13.3. Liquid
13.4. Powder
14. Bioactive Peptides Market, by Sales Channel
14.1. Introduction
14.2. Offline
14.3. Online
14.3.1. Brand Websites
14.3.2. E-Commerce Websites
15. Bioactive Peptides Market, by Application
15.1. Introduction
15.2. Cosmetics
15.3. Functional Foods
15.4. Nutraceuticals
15.5. Pharmaceuticals
16. Americas Bioactive Peptides Market
16.1. Introduction
16.2. Argentina
16.3. Brazil
16.4. Canada
16.5. Mexico
16.6. United States
17. Asia-Pacific Bioactive Peptides Market
17.1. Introduction
17.2. Australia
17.3. China
17.4. India
17.5. Indonesia
17.6. Japan
17.7. Malaysia
17.8. Philippines
17.9. Singapore
17.10. South Korea
17.11. Taiwan
17.12. Thailand
17.13. Vietnam
18. Europe, Middle East & Africa Bioactive Peptides Market
18.1. Introduction
18.2. Denmark
18.3. Egypt
18.4. Finland
18.5. France
18.6. Germany
18.7. Israel
18.8. Italy
18.9. Netherlands
18.10. Nigeria
18.11. Norway
18.12. Poland
18.13. Qatar
18.14. Russia
18.15. Saudi Arabia
18.16. South Africa
18.17. Spain
18.18. Sweden
18.19. Switzerland
18.20. Turkey
18.21. United Arab Emirates
18.22. United Kingdom
19. Competitive Landscape
19.1. Market Share Analysis, 2024
19.2. FPNV Positioning Matrix, 2024
19.3. Competitive Analysis
19.3.1. Abbott Laboratories
19.3.2. Ajinomoto Co., Inc.
19.3.3. Amgen Inc.
19.3.4. Archer Daniels Midland Company
19.3.5. Ashland Inc.
19.3.6. Bachem Holding AG
19.3.7. BASF SE
19.3.8. Clariant AG
19.3.9. CPC Scientific Inc.
19.3.10. Croda International Plc
19.3.11. Eli Lilly and Company
19.3.12. Evonik Industries AG
19.3.13. Ferring Pharmaceuticals Pvt. Ltd.
19.3.14. GenScript Biotech Corporation
19.3.15. Givaudan SA
19.3.16. Glanbia plc
19.3.17. Koninklijke DSM N.V.
19.3.18. LipoTrue SL
19.3.19. Lonza Group
19.3.20. Merck & Co., Inc.
19.3.21. Novo Nordisk A/S
19.3.22. Novozymes A/S
19.3.23. PeptiDream Inc.
19.3.24. Pfizer Inc.
19.3.25. PolyPeptide Group AG
19.3.26. Protagonist Therapeutics, Inc.
19.3.27. Symrise AG
19.3.28. Zealand Pharma A/S
20. ResearchAI
21. ResearchStatistics
22. ResearchContacts
23. ResearchArticles
24. Appendix
List of Figures
FIGURE 1. BIOACTIVE PEPTIDES MARKET MULTI-CURRENCY
FIGURE 2. BIOACTIVE PEPTIDES MARKET MULTI-LANGUAGE
FIGURE 3. BIOACTIVE PEPTIDES MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY SOURCE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY SOURCE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY TYPE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY PRODUCTION PROCESS, 2024 VS 2030 (%)
FIGURE 14. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY PRODUCTION PROCESS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY FUNCTION, 2024 VS 2030 (%)
FIGURE 16. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY FUNCTION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY FORMULATION, 2024 VS 2030 (%)
FIGURE 18. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY FORMULATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY SALES CHANNEL, 2024 VS 2030 (%)
FIGURE 20. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY SALES CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 22. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. AMERICAS BIOACTIVE PEPTIDES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. AMERICAS BIOACTIVE PEPTIDES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. UNITED STATES BIOACTIVE PEPTIDES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 26. UNITED STATES BIOACTIVE PEPTIDES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. ASIA-PACIFIC BIOACTIVE PEPTIDES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 28. ASIA-PACIFIC BIOACTIVE PEPTIDES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 29. EUROPE, MIDDLE EAST & AFRICA BIOACTIVE PEPTIDES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 30. EUROPE, MIDDLE EAST & AFRICA BIOACTIVE PEPTIDES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 31. BIOACTIVE PEPTIDES MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 32. BIOACTIVE PEPTIDES MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. BIOACTIVE PEPTIDES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY ENDOGENOUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY EXOGENOUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY ANIMAL DERIVED, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY DAIRY PROTEINS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY EGG WHITE PROTEINS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY MARINE PROTEINS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY MEAT PROTEINS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY ANIMAL DERIVED, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY MICROBIAL FERMENTATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY PLANT-BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY PEA, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY RICE, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY SOY, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY SYNTHETIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY DIPEPTIDE, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY OLIGOPEPTIDE, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY POLYPEPTIDE, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY TRIPEPTIDE, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY PRODUCTION PROCESS, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY CHEMICAL SYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY ENZYMATIC HYDROLYSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY FERMENTATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY RECOMBINANT PRODUCTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY ANTIHYPERTENSIVE, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY ANTIMICROBIAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY ANTIOXIDANT, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY IMMUNOMODULATORY, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY CAPSULE, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY LIQUID, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY POWDER, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY OFFLINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY ONLINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY BRAND WEBSITES, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY E-COMMERCE WEBSITES, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY COSMETICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY FUNCTIONAL FOODS, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY NUTRACEUTICALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY PHARMACEUTICALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. AMERICAS BIOACTIVE PEPTIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 54. AMERICAS BIOACTIVE PEPTIDES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 55. AMERICAS BIOACTIVE PEPTIDES MARKET SIZE, BY ANIMAL DERIVED, 2018-2030 (USD MILLION)
TABLE 56. AMERICAS BIOACTIVE PEPTIDES MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
TABLE 57. AMERICAS BIOACTIVE PEPTIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 58. AMERICAS BIOACTIVE PEPTIDES MARKET SIZE, BY PRODUCTION PROCESS, 2018-2030 (USD MILLION)
TABLE 59. AMERICAS BIOACTIVE PEPTIDES MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 60. AMERICAS BIOACTIVE PEPTIDES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 61. AMERICAS BIOACTIVE PEPTIDES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 62. AMERICAS BIOACTIVE PEPTIDES MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 63. AMERICAS BIOACTIVE PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 64. AMERICAS BIOACTIVE PEPTIDES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 65. ARGENTINA BIOACTIVE PEPTIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 66. ARGENTINA BIOACTIVE PEPTIDES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 67. ARGENTINA BIOACTIVE PEPTIDES MARKET SIZE, BY ANIMAL DERIVED, 2018-2030 (USD MILLION)
TABLE 68. ARGENTINA BIOACTIVE PEPTIDES MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
TABLE 69. ARGENTINA BIOACTIVE PEPTIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 70. ARGENTINA BIOACTIVE PEPTIDES MARKET SIZE, BY PRODUCTION PROCESS, 2018-2030 (USD MILLION)
TABLE 71. ARGENTINA BIOACTIVE PEPTIDES MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 72. ARGENTINA BIOACTIVE PEPTIDES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 73. ARGENTINA BIOACTIVE PEPTIDES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 74. ARGENTINA BIOACTIVE PEPTIDES MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 75. ARGENTINA BIOACTIVE PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 76. BRAZIL BIOACTIVE PEPTIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 77. BRAZIL BIOACTIVE PEPTIDES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 78. BRAZIL BIOACTIVE PEPTIDES MARKET SIZE, BY ANIMAL DERIVED, 2018-2030 (USD MILLION)
TABLE 79. BRAZIL BIOACTIVE PEPTIDES MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
TABLE 80. BRAZIL BIOACTIVE PEPTIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 81. BRAZIL BIOACTIVE PEPTIDES MARKET SIZE, BY PRODUCTION PROCESS, 2018-2030 (USD MILLION)
TABLE 82. BRAZIL BIOACTIVE PEPTIDES MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 83. BRAZIL BIOACTIVE PEPTIDES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 84. BRAZIL BIOACTIVE PEPTIDES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 85. BRAZIL BIOACTIVE PEPTIDES MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 86. BRAZIL BIOACTIVE PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 87. CANADA BIOACTIVE PEPTIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 88. CANADA BIOACTIVE PEPTIDES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 89. CANADA BIOACTIVE PEPTIDES MARKET SIZE, BY ANIMAL DERIVED, 2018-2030 (USD MILLION)
TABLE 90. CANADA BIOACTIVE PEPTIDES MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
TABLE 91. CANADA BIOACTIVE PEPTIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 92. CANADA BIOACTIVE PEPTIDES MARKET SIZE, BY PRODUCTION PROCESS, 2018-2030 (USD MILLION)
TABLE 93. CANADA BIOACTIVE PEPTIDES MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 94. CANADA BIOACTIVE PEPTIDES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 95. CANADA BIOACTIVE PEPTIDES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 96. CANADA BIOACTIVE PEPTIDES MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 97. CANADA BIOACTIVE PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 98. MEXICO BIOACTIVE PEPTIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 99. MEXICO BIOACTIVE PEPTIDES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 100. MEXICO BIOACTIVE PEPTIDES MARKET SIZE, BY ANIMAL DERIVED, 2018-2030 (USD MILLION)
TABLE 101. MEXICO BIOACTIVE PEPTIDES MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
TABLE 102. MEXICO BIOACTIVE PEPTIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 103. MEXICO BIOACTIVE PEPTIDES MARKET SIZE, BY PRODUCTION PROCESS, 2018-2030 (USD MILLION)
TABLE 104. MEXICO BIOACTIVE PEPTIDES MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 105. MEXICO BIOACTIVE PEPTIDES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 106. MEXICO BIOACTIVE PEPTIDES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 107. MEXICO BIOACTIVE PEPTIDES MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 108. MEXICO BIOACTIVE PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 109. UNITED STATES BIOACTIVE PEPTIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 110. UNITED STATES BIOACTIVE PEPTIDES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 111. UNITED STATES BIOACTIVE PEPTIDES MARKET SIZE, BY ANIMAL DERIVED, 2018-2030 (USD MILLION)
TABLE 112. UNITED STATES BIOACTIVE PEPTIDES MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
TABLE 113. UNITED STATES BIOACTIVE PEPTIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 114. UNITED STATES BIOACTIVE PEPTIDES MARKET SIZE, BY PRODUCTION PROCESS, 2018-2030 (USD MILLION)
TABLE 115. UNITED STATES BIOACTIVE PEPTIDES MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 116. UNITED STATES BIOACTIVE PEPTIDES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 117. UNITED STATES BIOACTIVE PEPTIDES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 118. UNITED STATES BIOACTIVE PEPTIDES MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 119. UNITED STATES BIOACTIVE PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 120. UNITED STATES BIOACTIVE PEPTIDES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 121. ASIA-PACIFIC BIOACTIVE PEPTIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 122. ASIA-PACIFIC BIOACTIVE PEPTIDES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 123. ASIA-PACIFIC BIOACTIVE PEPTIDES MARKET SIZE, BY ANIMAL DERIVED, 2018-2030 (USD MILLION)
TABLE 124. ASIA-PACIFIC BIOACTIVE PEPTIDES MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
TABLE 125. ASIA-PACIFIC BIOACTIVE PEPTIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 126. ASIA-PACIFIC BIOACTIVE PEPTIDES MARKET SIZE, BY PRODUCTION PROCESS, 2018-2030 (USD MILLION)
TABLE 127. ASIA-PACIFIC BIOACTIVE PEPTIDES MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 128. ASIA-PACIFIC BIOACTIVE PEPTIDES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 129. ASIA-PACIFIC BIOACTIVE PEPTIDES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 130. ASIA-PACIFIC BIOACTIVE PEPTIDES MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 131. ASIA-PACIFIC BIOACTIVE PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 132. ASIA-PACIFIC BIOACTIVE PEPTIDES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 133. AUSTRALIA BIOACTIVE PEPTIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 134. AUSTRALIA BIOACTIVE PEPTIDES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 135. AUSTRALIA BIOACTIVE PEPTIDES MARKET SIZE, BY ANIMAL DERIVED, 2018-2030 (USD MILLION)
TABLE 136. AUSTRALIA BIOACTIVE PEPTIDES MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
TABLE 137. AUSTRALIA BIOACTIVE PEPTIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 138. AUSTRALIA BIOACTIVE PEPTIDES MARKET SIZE, BY PRODUCTION PROCESS, 2018-2030 (USD MILLION)
TABLE 139. AUSTRALIA BIOACTIVE PEPTIDES MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 140. AUSTRALIA BIOACTIVE PEPTIDES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 141. AUSTRALIA BIOACTIVE PEPTIDES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 142. AUSTRALIA BIOACTIVE PEPTIDES MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 143. AUSTRALIA BIOACTIVE PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 144. CHINA BIOACTIVE PEPTIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 145. CHINA BIOACTIVE PEPTIDES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 146. CHINA BIOACTIVE PEPTIDES MARKET SIZE, BY ANIMAL DERIVED, 2018-2030 (USD MILLION)
TABLE 147. CHINA BIOACTIVE PEPTIDES MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
TABLE 148. CHINA BIOACTIVE PEPTIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 149. CHINA BIOACTIVE PEPTIDES MARKET SIZE, BY PRODUCTION PROCESS, 2018-2030 (USD MILLION)
TABLE 150. CHINA BIOACTIVE PEPTIDES MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 151. CHINA BIOACTIVE PEPTIDES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 152. CHINA BIOACTIVE PEPTIDES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 153. CHINA BIOACTIVE PEPTIDES MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 154. CHINA BIOACTIVE PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 155. INDIA BIOACTIVE PEPTIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 156. INDIA BIOACTIVE PEPTIDES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 157. INDIA BIOACTIVE PEPTIDES MARKET SIZE, BY ANIMAL DERIVED, 2018-2030 (USD MILLION)
TABLE 158. INDIA BIOACTIVE PEPTIDES MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
TABLE 159. INDIA BIOACTIVE PEPTIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 160. INDIA BIOACTIVE PEPTIDES MARKET SIZE, BY PRODUCTION PROCESS, 2018-2030 (USD MILLION)
TABLE 161. INDIA BIOACTIVE PEPTIDES MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 162. INDIA BIOACTIVE PEPTIDES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 163. INDIA BIOACTIVE PEPTIDES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 164. INDIA BIOACTIVE PEPTIDES MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 165. INDIA BIOACTIVE PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 166. INDONESIA BIOACTIVE PEPTIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 167. INDONESIA BIOACTIVE PEPTIDES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 168. INDONESIA BIOACTIVE PEPTIDES MARKET SIZE, BY ANIMAL DERIVED, 2018-2030 (USD MILLION)
TABLE 169. INDONESIA BIOACTIVE PEPTIDES MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
TABLE 170. INDONESIA BIOACTIVE PEPTIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 171. INDONESIA BIOACTIVE PEPTIDES MARKET SIZE, BY PRODUCTION PROCESS, 2018-2030 (USD MILLION)
TABLE 172. INDONESIA BIOACTIVE PEPTIDES MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 173. INDONESIA BIOACTIVE PEPTIDES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 174. INDONESIA BIOACTIVE PEPTIDES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 175. INDONESIA BIOACTIVE PEPTIDES MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 176. INDONESIA BIOACTIVE PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 177. JAPAN BIOACTIVE PEPTIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 178. JAPAN BIOACTIVE PEPTIDES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 179. JAPAN BIOACTIVE PEPTIDES MARKET SIZE, BY ANIMAL DERIVED, 2018-2030 (USD MILLION)
TABLE 180. JAPAN BIOACTIVE PEPTIDES MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
TABLE 181. JAPAN BIOACTIVE PEPTIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 182. JAPAN BIOACTIVE PEPTIDES MARKET SIZE, BY PRODUCTION PROCESS, 2018-2030 (USD MILLION)
TABLE 183. JAPAN BIOACTIVE PEPTIDES MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 184. JAPAN BIOACTIVE PEPTIDES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 185. JAPAN BIOACTIVE PEPTIDES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 186. JAPAN BIOACTIVE PEPTIDES MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 187. JAPAN BIOACTIVE PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 188. MALAYSIA BIOACTIVE PEPTIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 189. MALAYSIA BIOACTIVE PEPTIDES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 190. MALAYSIA BIOACTIVE PEPTIDES MARKET SIZE, BY ANIMAL DERIVED, 2018-2030 (USD MILLION)
TABLE 191. MALAYSIA BIOACTIVE PEPTIDES MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
TABLE 192. MALAYSIA BIOACTIVE PEPTIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 193. MALAYSIA BIOACTIVE PEPTIDES MARKET SIZE, BY PRODUCTION PROCESS, 2018-2030 (USD MILLION)
TABLE 194. MALAYSIA BIOACTIVE PEPTIDES MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 195. MALAYSIA BIOACTIVE PEPTIDES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 196. MALAYSIA BIOACTIVE PEPTIDES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 197. MALAYSIA BIOACTIVE PEPTIDES MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 198. MALAYSIA BIOACTIVE PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 199. PHILIPPINES BIOACTIVE PEPTIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 200. PHILIPPINES BIOACTIVE PEPTIDES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 201. PHILIPPINES BIOACTIVE PEPTIDES MARKET SIZE, BY ANIMAL DERIVED, 2018-2030 (USD MILLION)
TABLE 202. PHILIPPINES BIOACTIVE PEPTIDES MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
TABLE 203. PHILIPPINES BIOACTIVE PEPTIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 204. PHILIPPINES BIOACTIVE PEPTIDES MARKET SIZE, BY PRODUCTION PROCESS, 2018-2030 (USD MILLION)
TABLE 205. PHILIPPINES BIOACTIVE PEPTIDES MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 206. PHILIPPINES BIOACTIVE PEPTIDES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 207. PHILIPPINES BIOACTIVE PEPTIDES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 208. PHILIPPINES BIOACTIVE PEPTIDES MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 209. PHILIPPINES BIOACTIVE PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 210. SINGAPORE BIOACTIVE PEPTIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 211. SINGAPORE BIOACTIVE PEPTIDES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 212. SINGAPORE BIOACTIVE PEPTIDES MARKET SIZE, BY ANIMAL DERIVED, 2018-2030 (USD MILLION)
TABLE 213. SINGAPORE BIOACTIVE PEPTIDES MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
TABLE 214. SINGAPORE BIOACTIVE PEPTIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 215. SINGAPORE BIOACTIVE PEPTIDES MARKET SIZE, BY PRODUCTION PROCESS, 2018-2030 (USD MILLION)
TABLE 216. SINGAPORE BIOACTIVE PEPTIDES MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 217. SINGAPORE BIOACTIVE PEPTIDES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 218. SINGAPORE BIOACTIVE PEPTIDES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 219. SINGAPORE BIOACTIVE PEPTIDES MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 220. SINGAPORE BIOACTIVE PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 221. SOUTH KOREA BIOACTIVE PEPTIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 222. SOUTH KOREA BIOACTIVE PEPTIDES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 223. SOUTH KOREA BIOACTIVE PEPTIDES MARKET SIZE, BY ANIMAL DERIVED, 2018-2030 (USD MILLION)
TABLE 224. SOUTH KOREA BIOACTIVE PEPTIDES MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
TABLE 225. SOUTH KOREA BIOACTIVE PEPTIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 226. SOUTH KOREA BIOACTIVE PEPTIDES MARKET SIZE, BY PRODUCTION PROCESS, 2018-2030 (USD MILLION)
TABLE 227. SOUTH KOREA BIOACTIVE PEPTIDES MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 228. SOUTH KOREA BIOACTIVE PEPTIDES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 229. SOUTH KOREA BIOACTIVE PEPTIDES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 230. SOUTH KOREA BIOACTIVE PEPTIDES MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 231. SOUTH KOREA BIOACTIVE PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 232. TAIWAN BIOACTIVE PEPTIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 233. TAIWAN BIOACTIVE PEPTIDES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 234. TAIWAN BIOACTIVE PEPTIDES MARKET SIZE, BY ANIMAL DERIVED, 2018-2030 (USD MILLION)
TABLE 235. TAIWAN BIOACTIVE PEPTIDES MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
TABLE 236. TAIWAN BIOACTIVE PEPTIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 237. TAIWAN BIOACTIVE PEPTIDES MARKET SIZE, BY PRODUCTION PROCESS, 2018-2030 (USD MILLION)
TABLE 238. TAIWAN BIOACTIVE PEPTIDES MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 239. TAIWAN BIOACTIVE PEPTIDES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 240. TAIWAN BIOACTIVE PEPTIDES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 241. TAIWAN BIOACTIVE PEPTIDES MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 242. TAIWAN BIOACTIVE PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 243. THAILAND BIOACTIVE PEPTIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 244. THAILAND BIOACTIVE PEPTIDES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 245. THAILAND BIOACTIVE PEPTIDES MARKET SIZE, BY ANIMAL DERIVED, 2018-2030 (USD MILLION)
TABLE 246. THAILAND BIOACTIVE PEPTIDES MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
TABLE 247. THAILAND BIOACTIVE PEPTIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 248. THAILAND BIOACTIVE PEPTIDES MARKET SIZE, BY PRODUCTION PROCESS, 2018-2030 (USD MILLION)
TABLE 249. THAILAND BIOACTIVE PEPTIDES MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 250. THAILAND BIOACTIVE PEPTIDES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 251. THAILAND BIOACTIVE PEPTIDES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 252. THAILAND BIOACTIVE PEPTIDES MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 253. THAILAND BIOACTIVE PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 254. VIETNAM BIOACTIVE PEPTIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 255. VIETNAM BIOACTIVE PEPTIDES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 256. VIETNAM BIOACTIVE PEPTIDES MARKET SIZE, BY ANIMAL DERIVED, 2018-2030 (USD MILLION)
TABLE 257. VIETNAM BIOACTIVE PEPTIDES MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
TABLE 258. VIETNAM BIOACTIVE PEPTIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 259. VIETNAM BIOACTIVE PEPTIDES MARKET SIZE, BY PRODUCTION PROCESS, 2018-2030 (USD MILLION)
TABLE 260. VIETNAM BIOACTIVE PEPTIDES MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 261. VIETNAM BIOACTIVE PEPTIDES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 262. VIETNAM BIOACTIVE PEPTIDES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 263. VIETNAM BIOACTIVE PEPTIDES MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 264. VIETNAM BIOACTIVE PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 265. EUROPE, MIDDLE EAST & AFRICA BIOACTIVE PEPTIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 266. EUROPE, MIDDLE EAST & AFRICA BIOACTIVE PEPTIDES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 267. EUROPE, MIDDLE EAST & AFRICA BIOACTIVE PEPTIDES MARKET SIZE, BY ANIMAL DERIVED, 2018-2030 (USD MILLION)
TABLE 268. EUROPE, MIDDLE EAST & AFRICA BIOACTIVE PEPTIDES MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
TABLE 269. EUROPE, MIDDLE EAST & AFRICA BIOACTIVE PEPTIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 270. EUROPE, MIDDLE EAST & AFRICA BIOACTIVE PEPTIDES MARKET SIZE, BY PRODUCTION PROCESS, 2018-2030 (USD MILLION)
TABLE 271. EUROPE, MIDDLE EAST & AFRICA BIOACTIVE PEPTIDES MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 272. EUROPE, MIDDLE EAST & AFRICA BIOACTIVE PEPTIDES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 273. EUROPE, MIDDLE EAST & AFRICA BIOACTIVE PEPTIDES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 274. EUROPE, MIDDLE EAST & AFRICA BIOACTIVE PEPTIDES MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 275. EUROPE, MIDDLE EAST & AFRICA BIOACTIVE PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 276. EUROPE, MIDDLE EAST & AFRICA BIOACTIVE PEPTIDES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 277. DENMARK BIOACTIVE PEPTIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 278. DENMARK BIOACTIVE PEPTIDES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 279. DENMARK BIOACTIVE PEPTIDES MARKET SIZE, BY ANIMAL DERIVED, 2018-2030 (USD MILLION)
TABLE 280. DENMARK BIOACTIVE PEPTIDES MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
TABLE 281. DENMARK BIOACTIVE PEPTIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 282. DENMARK BIOACTIVE PEPTIDES MARKET SIZE, BY PRODUCTION PROCESS, 2018-2030 (USD MILLION)
TABLE 283. DENMARK BIOACTIVE PEPTIDES MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 284. DENMARK BIOACTIVE PEPTIDES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 285. DENMARK BIOACTIVE PEPTIDES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 286. DENMARK BIOACTIVE PEPTIDES MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 287. DENMARK BIOACTIVE PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 288. EGYPT BIOACTIVE PEPTIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 289. EGYPT BIOACTIVE PEPTIDES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 290. EGYPT BIOACTIVE PEPTIDES MARKET SIZE, BY ANIMAL DERIVED, 2018-2030 (USD MILLION)
TABLE 291. EGYPT BIOACTIVE PEPTIDES MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
TABLE 292. EGYPT BIOACTIVE PEPTIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 293. EGYPT BIOACTIVE PEPTIDES MARKET SIZE, BY PRODUCTION PROCESS, 2018-2030 (USD MILLION)
TABLE 294. EGYPT BIOACTIVE PEPTIDES MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 295. EGYPT BIOACTIVE PEPTIDES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 296. EGYPT BIOACTIVE PEPTIDES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 297. EGYPT BIOACTIVE PEPTIDES MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 298. EGYPT BIOACTIVE PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 299. FINLAND BIOACTIVE PEPTIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 300. FINLAND BIOACTIVE PEPTIDES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 301. FINLAND BIOACTIVE PEPTIDES MARKET SIZE, BY ANIMAL DERIVED, 2018-2030 (USD MILLION)
TABLE 302. FINLAND BIOACTIVE PEPTIDES MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
TABLE 303. FINLAND BIOACTIVE PEPTIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 304. FINLAND BIOACTIVE PEPTIDES MARKET SIZE, BY PRODUCTION PROCESS, 2018-2030 (USD MILLION)
TABLE 305. FINLAND BIOACTIVE PEPTIDES MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 306. FINLAND BIOACTIVE PEPTIDES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 307. FINLAND BIOACTIVE PEPTIDES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 308. FINLAND BIOACTIVE PEPTIDES MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 309. FINLAND BIOACTIVE PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 310. FRANCE BIOACTIVE PEPTIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 311. FRANCE BIOACTIVE PEPTIDES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 312. FRANCE BIOACTIVE PEPTIDES MARKET SIZE, BY ANIMAL DERIVED, 2018-2030 (USD MILLION)
TABLE 313. FRANCE BIOACTIVE PEPTIDES MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
TABLE 314. FRANCE BIOACTIVE PEPTIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 315. FRANCE BIOACTIVE PEPTIDES MARKET SIZE, BY PRODUCTION PROCESS, 2018-2030 (USD MILLION)
TABLE 316. FRANCE BIOACTIVE PEPTIDES MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 317. FRANCE BIOACTIVE PEPTIDES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 318. FRANCE BIOACTIVE PEPTIDES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 319. FRANCE BIOACTIVE PEPTIDES MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 320. FRANCE BIOACTIVE PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 321. GERMANY BIOACTIVE PEPTIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 322. GERMANY BIOACTIVE PEPTIDES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 323. GERMANY BIOACTIVE PEPTIDES MARKET SIZE, BY ANIMAL DERIVED, 2018-2030 (USD MILLION)
TABLE 324. GERMANY BIOACTIVE PEPTIDES MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
TABLE 325. GERMANY BIOACTIVE PEPTIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 326. GERMANY BIOACTIVE PEPTIDES MARKET SIZE, BY PRODUCTION PROCESS, 2018-2030 (USD MILLION)
TABLE 327. GERMANY BIOACTIVE PEPTIDES MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 328. GERMANY BIOACTIVE PEPTIDES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 329. GERMANY BIOACTIVE PEPTIDES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 330. GERMANY BIOACTIVE PEPTIDES MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 331. GERMANY BIOACTIVE PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 332. ISRAEL BIOACTIVE PEPTIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 333. ISRAEL BIOACTIVE PEPTIDES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 334. ISRAEL BIOACTIVE PEPTIDES MARKET SIZE, BY ANIMAL DERIVED, 2018-2030 (USD MILLION)
TABLE 335. ISRAEL BIOACTIVE PEPTIDES MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
TABLE 336. ISRAEL BIOACTIVE PEPTIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 337. ISRAEL BIOACTIVE PEPTIDES MARKET SIZE, BY PRODUCTION PROCESS, 2018-2030 (USD MILLION)
TABLE 338. ISRAEL BIOACTIVE PEPTIDES MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 339. ISRAEL BIOACTIVE PEPTIDES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 340. ISRAEL BIOACTIVE PEPTIDES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 341. ISRAEL BIOACTIVE PEPTIDES MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 342. ISRAEL BIOACTIVE PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 343. ITALY BIOACTIVE PEPTIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 344. ITALY BIOACTIVE PEPTIDES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 345. ITALY BIOACTIVE PEPTIDES MARKET SIZE, BY ANIMAL DERIVED, 2018-2030 (USD MILLION)
TABLE 346. ITALY BIOACTIVE PEPTIDES MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
TABLE 347. ITALY BIOACTIVE PEPTIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 348. ITALY BIOACTIVE PEPTIDES MARKET SIZE, BY PRODUCTION PROCESS, 2018-2030 (USD MILLION)
TABLE 349. ITALY BIOACTIVE PEPTIDES MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 350. ITALY BIOACTIVE PEPTIDES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 351. ITALY BIOACTIVE PEPTIDES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 352. ITALY BIOACTIVE PEPTIDES MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 353. ITALY BIOACTIVE PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 354. NETHERLANDS BIOACTIVE PEPTIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 355. NETHERLANDS BIOACTIVE PEPTIDES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 356. NETHERLANDS BIOACTIVE PEPTIDES MARKET SIZE, BY ANIMAL DERIVED, 2018-2030 (USD MILLION)
TABLE 357. NETHERLANDS BIOACTIVE PEPTIDES MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
TABLE 358. NETHERLANDS BIOACTIVE PEPTIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 359. NETHE

Companies Mentioned

  • Abbott Laboratories
  • Ajinomoto Co., Inc.
  • Amgen Inc.
  • Archer Daniels Midland Company
  • Ashland Inc.
  • Bachem Holding AG
  • BASF SE
  • Clariant AG
  • CPC Scientific Inc.
  • Croda International Plc
  • Eli Lilly and Company
  • Evonik Industries AG
  • Ferring Pharmaceuticals Pvt. Ltd.
  • GenScript Biotech Corporation
  • Givaudan SA
  • Glanbia plc
  • Koninklijke DSM N.V.
  • LipoTrue SL
  • Lonza Group
  • Merck & Co., Inc.
  • Novo Nordisk A/S
  • Novozymes A/S
  • PeptiDream Inc.
  • Pfizer Inc.
  • PolyPeptide Group AG
  • Protagonist Therapeutics, Inc.
  • Symrise AG
  • Zealand Pharma A/S

Methodology

Loading
LOADING...

Related Topics

Related Reports

2025 Bioactive Protein and Peptides Market Report - Industry Size, Competition, Trends and Growth Opportunities by Region - Forecast by Types and Applications (2024-2032) - Product Image

2025 Bioactive Protein and Peptides Market Report - Industry Size, Competition, Trends and Growth Opportunities by Region - Forecast by Types and Applications (2024-2032)

  • Report
  • 144 Pages
  • Global
From
2025 Bioactive Proteins In Coffee Market Report - Industry Size, Competition, Trends and Growth Opportunities by Region - Forecast by Types and Applications (2024-2032) - Product Image

2025 Bioactive Proteins In Coffee Market Report - Industry Size, Competition, Trends and Growth Opportunities by Region - Forecast by Types and Applications (2024-2032)

  • Report
  • 146 Pages
  • Global
From
Bioactive Glass Market by Type, Form, Application - Global Forecast 2025-2030 - Product Image

Bioactive Glass Market by Type, Form, Application - Global Forecast 2025-2030

  • Report
  • 182 Pages
  • Global
From
Bioactive Dressings Market - Cumulative Impact of United States Tariffs 2025 - Global Forecast to 2030 - Product Image

Bioactive Dressings Market - Cumulative Impact of United States Tariffs 2025 - Global Forecast to 2030

  • Report
  • 193 Pages
  • Global, United States Global, United States
From
Bioactive Wound Care Market Size, Share & Trends Analysis Report By Product (Moist, Antimicrobial, Active Dressing), By Application (General Surgery, Minimally invasive Surgery), By Region, And Segments Forecasts, 2024 - 2030 - Product Image

Bioactive Wound Care Market Size, Share & Trends Analysis Report By Product (Moist, Antimicrobial, Active Dressing), By Application (General Surgery, Minimally invasive Surgery), By Region, And Segments Forecasts, 2024 - 2030

  • Report
  • 100 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.